CINPHA
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Cinclus Pharma is a Swedish clinical-stage pharmaceutical company. The company is active in the development of molecules for the treatment of acid-related diseases. The company's lead drug candidate linaprazan glurate is being developed for the treatment of severe gastroesophageal reflux disease (GERD). Cinclus Pharma was founded in 2014 and is headquartered in Stockholm, Sweden.
Læs mereDelårsrapport Q2'26
Delårsrapport Q3'26
Omsætning mio.
EBIT-% (adj.)
EPS (adj.)
Udbytte %
Gå ikke glip af noget - opret en konto og få alle de mulige fordele